Craig A Johnson Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

Craig A Johnson is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 14,592 shares of AUPH, which is worth approximately $223,987. The most recent transaction as insider was on Nov 21, 2025, when has been sold 6,039 shares (Common Shares) at a price of $15.68 per share, resulting in proceeds of $94,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.6K
29.27% 3M change
29.27% 12M change
Total Value Held $223,987

Craig A Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2025
SELL
Payment of exercise price or tax liability
$94,691 $15.68 p/Share
6,039 Reduced 29.27%
14,592 Common Shares
Nov 21 2024
BUY
Grant, award, or other acquisition
-
20,631 Added 50.0%
20,631 Common Shares

Also insider at

ODTC
Odonate Therapeutics, Inc. Financial Services
Director
LJPC
LA JOLLA PHARMACEUTICAL CO Healthcare
Director
HRTX
HERON THERAPEUTICS, INC. Healthcare
MRTX
Mirati Therapeutics, Inc. Healthcare
CAJ

Craig A Johnson

Director
Waltham, MA

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH